688198 佰仁医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.96010.0359.0995.6067.053
总资产报酬率 ROA (%)4.4999.1918.6055.3836.811
投入资产回报率 ROIC (%)4.8539.8859.0375.5707.030

边际利润分析
销售毛利率 (%)88.56589.84589.37588.24388.893
营业利润率 (%)20.24132.59836.39320.89236.932
息税前利润/营业总收入 (%)18.22732.36235.62919.20835.859
净利润/营业总收入 (%)17.10629.51931.98020.35730.738

收益指标分析
经营活动净收益/利润总额(%)82.63583.47279.29164.94174.714
价值变动净收益/利润总额(%)14.50814.89321.01431.95328.358
营业外收支净额/利润总额(%)-3.724-0.668-1.209-5.735-1.356

偿债能力分析
流动比率 (X)8.9958.42911.45123.31126.296
速动比率 (X)8.2207.99610.95322.71125.764
资产负债率 (%)9.27210.4346.8224.1454.087
带息债务/全部投入资本 (%)-2.422-2.432-0.9430.136-0.098
股东权益/带息债务 (%)-4,045.994-4,017.473-10,542.42872,852.436-101,586.479
股东权益/负债合计 (%)985.805862.7531,368.3902,315.8072,350.592
利息保障倍数 (X)-14.154-1,704.972-108.218-34.876-61.971

营运能力分析
应收账款周转天数 (天)82.04668.70559.99148.88128.081
存货周转天数 (天)347.039317.476306.770232.915241.758